MGMT and glioblastoma: A significantly higher MGMT promoter methylation in carriers of the T allele has been described recently in glioblastoma[24], diffuse large B-cell lymphoma[37], colorectal carcinoma[25,26], pleural mesothelioma[27], and lung cancer[28].